ReP USP - Resultado da busca

Artigo de periodico
Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus (2020)
Morais-Faria, Karina; Palmier, Natalia Rangel; Correia, Jaqueline de Lima; Castro Junior, Gilberto de Castro ; Dias, Reinaldo Brito; Pinto, Henrique da Graca; Lopes, Marcio Ajudarte; Ribeiro, Ana Carolina Prado; Brandao, Thais Bianca; Santos-Silva, Alan Roger
Source: Supportive care in cancer. Unidade: FM
Subjects: ESTOMATITE, ESTUDOS RETROSPECTIVOS, ESTUDOS DE COORTES, NEOPLASIAS DE CABEÇA E PESCOÇO, RADIOTERAPIA, TRISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS-FARIA, Karina et al. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, v. 28, n. 9, p. 4345-4352, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00520-019-05241-x. Acesso em: 05 nov. 2024.
APA
Morais-Faria, K., Palmier, N. R., Correia, J. de L., Castro Junior, G. de C., Dias, R. B., Pinto, H. da G., et al. (2020). Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, 28( 9), 4345-4352. doi:10.1007/s00520-019-05241-x
NLM
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Vancouver
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00520-019-05241-x
Artigo de periodico
Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? (2020)
Ramos, Marcus F. K. P; Pereira, Marina A; Amorim, Larissa C; Mello, Evandro S. de; Faraj, Sheila F; Ribeiro Junior, Ulysses ; Hoff, Paulo Marcelo Gehm ; Cecconello, Ivan ; Castria, Tiago B. de
Source: Journal of surgical oncology. Unidade: FM
Subjects: ADENOCARCINOMA, ANTÍGENOS, HERPES SIMPLES, ESTUDOS RETROSPECTIVOS, NEOPLASIAS GÁSTRICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Marcus F. K. P et al. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?. Journal of surgical oncology, v. 121, n. 5, p. 804-813, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25792. Acesso em: 05 nov. 2024.
APA
Ramos, M. F. K. P., Pereira, M. A., Amorim, L. C., Mello, E. S. de, Faraj, S. F., Ribeiro Junior, U., et al. (2020). Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? Journal of surgical oncology, 121( 5), 804-813. doi:10.1002/jso.25792
NLM
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1002/jso.25792
Vancouver
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1002/jso.25792
Artigo de periodico
Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC (2020)
Cronemberger, Eduardo; Baldotto, Clarissa; Marinho, Felipe; Marchi, Pedro De; Araujo, Luiz Henrique; Franke, Fabio; Salles, Paulo; Calabrich, Aknar; Almeida, Thais; Castro Junior, Gilberto de Castro
Source: Clinics. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, QUIMIOTERAPIA, GENÉTICA, TÉCNICAS DE DIAGNÓSTICO MOLECULAR, MUTAÇÃO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRONEMBERGER, Eduardo et al. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1777. Acesso em: 05 nov. 2024.
APA
Cronemberger, E., Baldotto, C., Marinho, F., Marchi, P. D., Araujo, L. H., Franke, F., et al. (2020). Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC. Clinics, 75. doi:10.6061/clinics/2020/e1777
NLM
Cronemberger E, Baldotto C, Marinho F, Marchi PD, Araujo LH, Franke F, Salles P, Calabrich A, Almeida T, Castro Junior G de C. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2020/e1777
Vancouver
Cronemberger E, Baldotto C, Marinho F, Marchi PD, Araujo LH, Franke F, Salles P, Calabrich A, Almeida T, Castro Junior G de C. Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2020/e1777
Artigo de periodico
Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma (2020)
Lima, Graziele Aparecida Simoes; Lopez, Rossana Veronica Mendoza; Freitas, Ricardo Miguel Costa de; Willegaignon, Jose; Sapienza, Marcelo Tatit ; Chammas, Maria Christina; Coura-Filho, George Barberio
Source: Journal of ultrasound in medicine. Unidade: FM
Subjects: RADIOISÓTOPOS, ESTUDOS RETROSPECTIVOS, GLÂNDULAS SALIVARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Graziele Aparecida Simoes et al. Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma. Journal of ultrasound in medicine, v. 39, n. 9, p. 1811-1818, 2020Tradução . . Disponível em: https://doi.org/10.1002/jum.15289. Acesso em: 05 nov. 2024.
APA
Lima, G. A. S., Lopez, R. V. M., Freitas, R. M. C. de, Willegaignon, J., Sapienza, M. T., Chammas, M. C., & Coura-Filho, G. B. (2020). Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma. Journal of ultrasound in medicine, 39( 9), 1811-1818. doi:10.1002/jum.15289
NLM
Lima GAS, Lopez RVM, Freitas RMC de, Willegaignon J, Sapienza MT, Chammas MC, Coura-Filho GB. Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma [Internet]. Journal of ultrasound in medicine. 2020 ; 39( 9): 1811-1818.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1002/jum.15289
Vancouver
Lima GAS, Lopez RVM, Freitas RMC de, Willegaignon J, Sapienza MT, Chammas MC, Coura-Filho GB. Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma [Internet]. Journal of ultrasound in medicine. 2020 ; 39( 9): 1811-1818.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1002/jum.15289
Artigo de periodico
Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience (2020)
Franco, Rejane; Matos, Leandro Luongo de; Kulcsar, Marco Aurelio Vamondes; Castro Junior, Gilberto de ; Marta, Gustavo Nader
Source: Clinics. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PERÍODO PÓS-OPERATÓRIO, ESTUDOS RETROSPECTIVOS, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Rejane et al. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1615. Acesso em: 05 nov. 2024.
APA
Franco, R., Matos, L. L. de, Kulcsar, M. A. V., Castro Junior, G. de, & Marta, G. N. (2020). Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, 75. doi:10.6061/clinics/2020/e1615
NLM
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2020/e1615
Vancouver
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2020/e1615
Artigo de periodico
Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil (2019)
Libera, Larisse Silva Dalla; Carvalho, Keila Patricia Almeida de; Ramos, Jessica Enocencio Porto; Cabral, Lazara Alyne Oliveira; Alencar, Rita de Cassia Goncalves de; Villa, Luisa Lina ; Alves, Rosane Ribeiro Figueiro; Santos, Silvia Helena Rabelo; Carneiro, Megmar Aparecida dos Santos; Saddi, Vera Aparecida
Source: Journal of oncology. Unidade: FM
Subjects: HPV, NEOPLASIAS RETAIS, GENÓTIPOS, PROGNÓSTICO, PREVALÊNCIA, ESTUDOS RETROSPECTIVOS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIBERA, Larisse Silva Dalla et al. Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil. Journal of oncology, v. 2019, 2019Tradução . . Disponível em: https://doi.org/10.1155/2019/6018269. Acesso em: 05 nov. 2024.
APA
Libera, L. S. D., Carvalho, K. P. A. de, Ramos, J. E. P., Cabral, L. A. O., Alencar, R. de C. G. de, Villa, L. L., et al. (2019). Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil. Journal of oncology, 2019. doi:10.1155/2019/6018269
NLM
Libera LSD, Carvalho KPA de, Ramos JEP, Cabral LAO, Alencar R de CG de, Villa LL, Alves RRF, Santos SHR, Carneiro MA dos S, Saddi VA. Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil [Internet]. Journal of oncology. 2019 ; 2019[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2019/6018269
Vancouver
Libera LSD, Carvalho KPA de, Ramos JEP, Cabral LAO, Alencar R de CG de, Villa LL, Alves RRF, Santos SHR, Carneiro MA dos S, Saddi VA. Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil [Internet]. Journal of oncology. 2019 ; 2019[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2019/6018269
Artigo de periodico
Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community Hospital in Brazil (2019)
Victor, Carolina Ribeiro; Fujiki, Femanda Kaori; Takeda, Flavio Roberto; Hoff, Paulo Marcelo Gehm ; Castria, Tiago Biachi de
Source: Journal of global oncology. Unidade: FM
Subjects: NEOPLASIAS ESOFÁGICAS, METÁSTASE NEOPLÁSICA, HOSPITAIS COMUNITÁRIOS, QUIMIOTERAPIA, ESTUDOS RETROSPECTIVOS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTOR, Carolina Ribeiro et al. Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community Hospital in Brazil. Journal of global oncology, v. 5, 2019Tradução . . Disponível em: https://doi.org/10.1200/JGO.19.00103. Acesso em: 05 nov. 2024.
APA
Victor, C. R., Fujiki, F. K., Takeda, F. R., Hoff, P. M. G., & Castria, T. B. de. (2019). Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community Hospital in Brazil. Journal of global oncology, 5. doi:10.1200/JGO.19.00103
NLM
Victor CR, Fujiki FK, Takeda FR, Hoff PMG, Castria TB de. Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community Hospital in Brazil [Internet]. Journal of global oncology. 2019 ; 5[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.19.00103
Vancouver
Victor CR, Fujiki FK, Takeda FR, Hoff PMG, Castria TB de. Safety and effectiveness of chemotherapy for metastatic esophageal cancer in a community Hospital in Brazil [Internet]. Journal of global oncology. 2019 ; 5[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.19.00103
Artigo de periodico
Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation (2019)
Rezende, Ana Carolina Pires de; Weltman, Eduardo ; Chen, Michael Jenwei; Helito, Juliana Karassawa; Carvalho, Icaro Thiago de; Sakuraba, Roberto Kenji; Silva, Nasjla Saba; Cappellano, Andrea Maria; Hamerschlak, Nelson
Source: PLOS ONE. Unidade: FM
Subjects: ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS, QUIMIOTERAPIA COMBINADA, ANTINEOPLÁSICOS, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE, Ana Carolina Pires de et al. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation. PLOS ONE, v. 14, n. 12, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0226350. Acesso em: 05 nov. 2024.
APA
Rezende, A. C. P. de, Weltman, E., Chen, M. J., Helito, J. K., Carvalho, I. T. de, Sakuraba, R. K., et al. (2019). Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation. PLOS ONE, 14( 12). doi:10.1371/journal.pone.0226350
NLM
Rezende ACP de, Weltman E, Chen MJ, Helito JK, Carvalho IT de, Sakuraba RK, Silva NS, Cappellano AM, Hamerschlak N. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation [Internet]. PLOS ONE. 2019 ; 14( 12):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1371/journal.pone.0226350
Vancouver
Rezende ACP de, Weltman E, Chen MJ, Helito JK, Carvalho IT de, Sakuraba RK, Silva NS, Cappellano AM, Hamerschlak N. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation [Internet]. PLOS ONE. 2019 ; 14( 12):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1371/journal.pone.0226350
Artigo de periodico
Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings (2019)
Bonadio, Renata Colombo; Divino, Paulo Henrique Amor; Obando, Jorge Santiago Madero; Lima, Karolina Cayres Alvino; Recchimuzzi, Debora Zachello; Kruger, Jaime Arthur Pirola; Saragiotto, Daniel Fernandes; Capareli, Fernanda C.; Hoff, Paulo Marcelo Gehm
Source: Journal of global oncology. Unidade: FM
Subjects: ENVELHECIMENTO, NEOPLASIAS COLORRETAIS, NEOPLASIAS HEPÁTICAS, MEIA IDADE, METÁSTASE NEOPLÁSICA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONADIO, Renata Colombo et al. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings. Journal of global oncology, v. 5, 2019Tradução . . Disponível em: https://doi.org/10.1200/JGO.19.00180. Acesso em: 05 nov. 2024.
APA
Bonadio, R. C., Divino, P. H. A., Obando, J. S. M., Lima, K. C. A., Recchimuzzi, D. Z., Kruger, J. A. P., et al. (2019). Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings. Journal of global oncology, 5. doi:10.1200/JGO.19.00180
NLM
Bonadio RC, Divino PHA, Obando JSM, Lima KCA, Recchimuzzi DZ, Kruger JAP, Saragiotto DF, Capareli FC, Hoff PMG. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings [Internet]. Journal of global oncology. 2019 ; 5[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.19.00180
Vancouver
Bonadio RC, Divino PHA, Obando JSM, Lima KCA, Recchimuzzi DZ, Kruger JAP, Saragiotto DF, Capareli FC, Hoff PMG. Conversion chemotherapy with a modified FLOX regimen for Borderline or unresectable liver metastases from colorectal cancer: an alternative for limited-resources settings [Internet]. Journal of global oncology. 2019 ; 5[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.19.00180
Artigo de periodico
Stereotactic body radiation therapy for biopsy-proven primary non-small-cell lung cancer: experience of patients with inoperable cancer at a Single Brazilian Institution (2018)
V, Carlos E. C. Abreu; Moraes, Fabio Y; Miranda, Fabiana A; Siqueira, Gabriela S. M; Gadia, Rafael; Haddad, Cecilia K; Carvalho, Heloisa de Andrade
Source: Journal of global oncology. Unidade: FM
Subjects: RADIOTERAPIA, NEOPLASIAS PULMONARES, CARCINOMA BRONCOGÊNICO, BIÓPSIA, RADIAÇÃO IONIZANTE, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
V, Carlos E. C. Abreu et al. Stereotactic body radiation therapy for biopsy-proven primary non-small-cell lung cancer: experience of patients with inoperable cancer at a Single Brazilian Institution. Journal of global oncology, v. 4, 2018Tradução . . Disponível em: https://doi.org/10.1200/JGO.18.00020. Acesso em: 05 nov. 2024.
APA
V, C. E. C. A., Moraes, F. Y., Miranda, F. A., Siqueira, G. S. M., Gadia, R., Haddad, C. K., & Carvalho, H. de A. (2018). Stereotactic body radiation therapy for biopsy-proven primary non-small-cell lung cancer: experience of patients with inoperable cancer at a Single Brazilian Institution. Journal of global oncology, 4. doi:10.1200/JGO.18.00020
NLM
V CECA, Moraes FY, Miranda FA, Siqueira GSM, Gadia R, Haddad CK, Carvalho H de A. Stereotactic body radiation therapy for biopsy-proven primary non-small-cell lung cancer: experience of patients with inoperable cancer at a Single Brazilian Institution [Internet]. Journal of global oncology. 2018 ; 4[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.18.00020
Vancouver
V CECA, Moraes FY, Miranda FA, Siqueira GSM, Gadia R, Haddad CK, Carvalho H de A. Stereotactic body radiation therapy for biopsy-proven primary non-small-cell lung cancer: experience of patients with inoperable cancer at a Single Brazilian Institution [Internet]. Journal of global oncology. 2018 ; 4[citado 2024 nov. 05 ] Available from: https://doi.org/10.1200/JGO.18.00020
Artigo de periodico
Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors (2018)
Camara-de-souza, A. B.; Giannella, Maria Lúcia Cardillo Côrrea; Rocha, Manoel de Souza; Bacchella, Telesforo; Machado, Marcel Cerqueira César
Source: Pancreatology. Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS, ESTUDOS RETROSPECTIVOS, SOBREVIDA, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARA-DE-SOUZA, A. B. et al. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology, v. 18, n. 3, p. 298-303, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pan.2018.01.009. Acesso em: 05 nov. 2024.
APA
Camara-de-souza, A. B., Giannella, M. L. C. C., Rocha, M. de S., Bacchella, T., & Machado, M. C. C. (2018). Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology, 18( 3), 298-303. doi:10.1016/j.pan.2018.01.009
NLM
Camara-de-souza AB, Giannella MLCC, Rocha M de S, Bacchella T, Machado MCC. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors [Internet]. Pancreatology. 2018 ; 18( 3): 298-303.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.pan.2018.01.009
Vancouver
Camara-de-souza AB, Giannella MLCC, Rocha M de S, Bacchella T, Machado MCC. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors [Internet]. Pancreatology. 2018 ; 18( 3): 298-303.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.pan.2018.01.009
Trabalho de evento-resumo periodico
High hepatic tumor burden and cardiovascular comorbidities linked to carcinoid heart disease (2017)
Mesquita, M. C; Silva, C. A. C; Silva, C. M. P. D. C; Soeiro, M. C. Feres Almeida; Hajjar, Ludmilla Abrahao; Hoff, Paulo Marcelo Gehm; Riechelmann, R. S. P
Source: Annals of oncology. Conference titles: 42nd European-Society-for-Medical-Oncology Congress (ESMO). Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, COMORBIDADE, NEOPLASIAS CARDÍACAS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MESQUITA, M. C et al. High hepatic tumor burden and cardiovascular comorbidities linked to carcinoid heart disease. Annals of oncology. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://observatorio.fm.usp.br/handle/OPI/25154. Acesso em: 05 nov. 2024. , 2017
APA
Mesquita, M. C., Silva, C. A. C., Silva, C. M. P. D. C., Soeiro, M. C. F. A., Hajjar, L. A., Hoff, P. M. G., & Riechelmann, R. S. P. (2017). High hepatic tumor burden and cardiovascular comorbidities linked to carcinoid heart disease. Annals of oncology. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25154
NLM
Mesquita MC, Silva CAC, Silva CMPDC, Soeiro MCFA, Hajjar LA, Hoff PMG, Riechelmann RSP. High hepatic tumor burden and cardiovascular comorbidities linked to carcinoid heart disease [Internet]. Annals of oncology. 2017 ; 28[citado 2024 nov. 05 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25154
Vancouver
Mesquita MC, Silva CAC, Silva CMPDC, Soeiro MCFA, Hajjar LA, Hoff PMG, Riechelmann RSP. High hepatic tumor burden and cardiovascular comorbidities linked to carcinoid heart disease [Internet]. Annals of oncology. 2017 ; 28[citado 2024 nov. 05 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25154
Artigo de periodico
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective (2016)
Zattar-Ramos, L. C.; Bezerra, R. O.; Siqueira, L. T.; Marques, D. T.; Menezes, M. R.; Herman, P.; Machado, M. A. C.; Cerri, G. G.; Leite, C. C.
Source: Abdominal Radiology. Unidade: FM
Subjects: METÁSTASE NEOPLÁSICA, RESSECÇÃO, ESTUDOS RETROSPECTIVOS, PROCEDIMENTOS CIRÚRGICOS DO SISTEMA DIGESTÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZATTAR-RAMOS, L. C. et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective. Abdominal Radiology, v. 41, n. 11, p. 2150-2160, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00261-016-0832-6. Acesso em: 05 nov. 2024.
APA
Zattar-Ramos, L. C., Bezerra, R. O., Siqueira, L. T., Marques, D. T., Menezes, M. R., Herman, P., et al. (2016). Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective. Abdominal Radiology, 41( 11), 2150-2160. doi:10.1007/s00261-016-0832-6
NLM
Zattar-Ramos LC, Bezerra RO, Siqueira LT, Marques DT, Menezes MR, Herman P, Machado MAC, Cerri GG, Leite CC. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective [Internet]. Abdominal Radiology. 2016 ; 41( 11): 2150-2160.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00261-016-0832-6
Vancouver
Zattar-Ramos LC, Bezerra RO, Siqueira LT, Marques DT, Menezes MR, Herman P, Machado MAC, Cerri GG, Leite CC. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist’s perspective [Internet]. Abdominal Radiology. 2016 ; 41( 11): 2150-2160.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00261-016-0832-6
Artigo de periodico
Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Osteoid Osteoma: A Case Series Report (2016)
Rovella, Marcello S.; Martins, Guilherme L. P.; Cavalcanti, Conrado F. A.; Bor-Seng-Shu, Edson; Camargo, Olavo P.; Cerri, Giovanni G.; Menezes, Marcos R.
Source: Ultrasound in Medicine and Biology. Unidade: FM
Subjects: NEOPLASIAS ÓSSEAS, ESTUDOS RETROSPECTIVOS, RESSONÂNCIA MAGNÉTICA NUCLEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVELLA, Marcello S. et al. Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Osteoid Osteoma: A Case Series Report. Ultrasound in Medicine and Biology, v. 42, n. 4, p. 919-923, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ultrasmedbio.2015.11.003. Acesso em: 05 nov. 2024.
APA
Rovella, M. S., Martins, G. L. P., Cavalcanti, C. F. A., Bor-Seng-Shu, E., Camargo, O. P., Cerri, G. G., & Menezes, M. R. (2016). Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Osteoid Osteoma: A Case Series Report. Ultrasound in Medicine and Biology, 42( 4), 919-923. doi:10.1016/j.ultrasmedbio.2015.11.003
NLM
Rovella MS, Martins GLP, Cavalcanti CFA, Bor-Seng-Shu E, Camargo OP, Cerri GG, Menezes MR. Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Osteoid Osteoma: A Case Series Report [Internet]. Ultrasound in Medicine and Biology. 2016 ; 42( 4): 919-923.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ultrasmedbio.2015.11.003
Vancouver
Rovella MS, Martins GLP, Cavalcanti CFA, Bor-Seng-Shu E, Camargo OP, Cerri GG, Menezes MR. Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Osteoid Osteoma: A Case Series Report [Internet]. Ultrasound in Medicine and Biology. 2016 ; 42( 4): 919-923.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ultrasmedbio.2015.11.003
Trabalho de evento-resumo periodico
Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis (2015)
Fernandes, Gustavo Dos Santos; Xavier, Flavia; Braghiroli, Maria Ignez; Machado, Karime; Souza, Karla Teixeira; Paterlini, Ana Carolina Carvalho Rocha; Ferreira, Fernando Sergio Blumm; Hoff, Paulo Marcelo
Source: Journal of Clinical Oncology. Conference titles: ASCO Annual Meeting. Unidade: FM
Subjects: NEOPLASIAS (COMPLICAÇÕES), QUIMIOTERAPIA (EFEITOS ADVERSOS), ESTUDOS RETROSPECTIVOS, TROMBOEMBOLISMO (ETIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Gustavo Dos Santos et al. Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e20643?sid=69988bce-10fd-4808-a054-d0c1d39d5fff. Acesso em: 05 nov. 2024. , 2015
APA
Fernandes, G. D. S., Xavier, F., Braghiroli, M. I., Machado, K., Souza, K. T., Paterlini, A. C. C. R., et al. (2015). Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e20643?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
NLM
Fernandes GDS, Xavier F, Braghiroli MI, Machado K, Souza KT, Paterlini ACCR, Ferreira FSB, Hoff PM. Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 nov. 05 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e20643?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
Vancouver
Fernandes GDS, Xavier F, Braghiroli MI, Machado K, Souza KT, Paterlini ACCR, Ferreira FSB, Hoff PM. Efficacy and safety of rivaroxaban in Brazilian oncologic patients with thrombosis [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 nov. 05 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e20643?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
Artigo de periodico
Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study (2013)
Pontes, Luciola de Barros; Loureiro, Luiz Victor Maia; Koch, Ludmila O.; Karnakis, Theodora; Guendelmann, Rafael Aliosha Kalilks; Weltman, Eduardo; Malheiros, Suzana Maria Fleury
Source: Journal of Geriatric Oncology. Unidade: FM
Subjects: IDOSOS, ONCOLOGIA, NEOPLASIAS CEREBRAIS (QUIMIOTERAPIA), PROGNÓSTICO, ESTUDOS RETROSPECTIVOS, GERIATRIA, PROCEDIMENTOS NEUROCIRÚRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTES, Luciola de Barros et al. Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study. Journal of Geriatric Oncology, v. 4, n. 4, p. 388-393, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.jgo.2013.07.005. Acesso em: 05 nov. 2024.
APA
Pontes, L. de B., Loureiro, L. V. M., Koch, L. O., Karnakis, T., Guendelmann, R. A. K., Weltman, E., & Malheiros, S. M. F. (2013). Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study. Journal of Geriatric Oncology, 4( 4), 388-393. doi:10.1016/j.jgo.2013.07.005
NLM
Pontes L de B, Loureiro LVM, Koch LO, Karnakis T, Guendelmann RAK, Weltman E, Malheiros SMF. Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study [Internet]. Journal of Geriatric Oncology. 2013 ; 4( 4): 388-393.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jgo.2013.07.005
Vancouver
Pontes L de B, Loureiro LVM, Koch LO, Karnakis T, Guendelmann RAK, Weltman E, Malheiros SMF. Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study [Internet]. Journal of Geriatric Oncology. 2013 ; 4( 4): 388-393.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jgo.2013.07.005
Artigo de periodico
Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors (2013)
Ferrarotto, Renata; Testa, Laura; Riechelmann, Rachel P.; Sahade, Marina; Siqueira, Luiz T.; Costa, Frederico P.; Hoff, Paulo M.
Source: Rare tumors. Unidade: FM
Subjects: NEOPLASIA ENDÓCRINA MÚLTIPLA (TERAPIA), ESTUDOS RETROSPECTIVOS, METÁSTASE NEOPLÁSICA, BIÓPSIA, PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata et al. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors. Rare tumors, v. 5, n. 3, p. 121-125, 2013Tradução . . Disponível em: https://doi.org/10.4081/rt.2013.e35. Acesso em: 05 nov. 2024.
APA
Ferrarotto, R., Testa, L., Riechelmann, R. P., Sahade, M., Siqueira, L. T., Costa, F. P., & Hoff, P. M. (2013). Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors. Rare tumors, 5( 3), 121-125. doi:10.4081/rt.2013.e35
NLM
Ferrarotto R, Testa L, Riechelmann RP, Sahade M, Siqueira LT, Costa FP, Hoff PM. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors [Internet]. Rare tumors. 2013 ; 5( 3): 121-125.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4081/rt.2013.e35
Vancouver
Ferrarotto R, Testa L, Riechelmann RP, Sahade M, Siqueira LT, Costa FP, Hoff PM. Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors [Internet]. Rare tumors. 2013 ; 5( 3): 121-125.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4081/rt.2013.e35
Artigo de periodico
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib (2013)
Smith, John C.; Brooks, Laura; Hoff, Paulo M.; McWalter, Gael; Dearden, Simon; Morgan, Shethah R.; Wilson, David; Robertson, Jane D.; Jürgensmeier, Juliane M.
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (QUIMIOTERAPIA), MUTAÇÃO GENÉTICA, ESTUDOS RETROSPECTIVOS, PROGNÓSTICO, BIOMARCADORES, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITH, John C. et al. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer, v. 49, n. 10, p. 2424-2432, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2013.02.023. Acesso em: 05 nov. 2024.
APA
Smith, J. C., Brooks, L., Hoff, P. M., McWalter, G., Dearden, S., Morgan, S. R., et al. (2013). KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer, 49( 10), 2424-2432. doi:10.1016/j.ejca.2013.02.023
NLM
Smith JC, Brooks L, Hoff PM, McWalter G, Dearden S, Morgan SR, Wilson D, Robertson JD, Jürgensmeier JM. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib [Internet]. European Journal of Cancer. 2013 ; 49( 10): 2424-2432.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ejca.2013.02.023
Vancouver
Smith JC, Brooks L, Hoff PM, McWalter G, Dearden S, Morgan SR, Wilson D, Robertson JD, Jürgensmeier JM. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib [Internet]. European Journal of Cancer. 2013 ; 49( 10): 2424-2432.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ejca.2013.02.023
Artigo de periodico
Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas (2013)
Munhoz, Rodrigo Ramella; Rego, Juliana Florinda de Mendonca; Ferrari, Anezka Rubim de Celis; Braghiroli, Maria Ignez; Bariani, Giovanni Mendonca; Hoff, Paulo Marcelo; Costa, Frederico Perego; Pfiffer, Tulio Eduardo Flesch; Riechelmann, Rachel
Source: Rare tumors. Unidade: FM
Subjects: NEOPLASIA ENDÓCRINA MÚLTIPLA, ESTUDOS RETROSPECTIVOS, METÁSTASE NEOPLÁSICA (DIAGNÓSTICO), PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS (USO TERAPÊUTICO), CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNHOZ, Rodrigo Ramella et al. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare tumors, v. 5, n. 3, p. 135-139, 2013Tradução . . Disponível em: https://doi.org/10.4081/rt.2013.e39. Acesso em: 05 nov. 2024.
APA
Munhoz, R. R., Rego, J. F. de M., Ferrari, A. R. de C., Braghiroli, M. I., Bariani, G. M., Hoff, P. M., et al. (2013). Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare tumors, 5( 3), 135-139. doi:10.4081/rt.2013.e39
NLM
Munhoz RR, Rego JF de M, Ferrari AR de C, Braghiroli MI, Bariani GM, Hoff PM, Costa FP, Pfiffer TEF, Riechelmann R. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas [Internet]. Rare tumors. 2013 ; 5( 3): 135-139.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4081/rt.2013.e39
Vancouver
Munhoz RR, Rego JF de M, Ferrari AR de C, Braghiroli MI, Bariani GM, Hoff PM, Costa FP, Pfiffer TEF, Riechelmann R. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas [Internet]. Rare tumors. 2013 ; 5( 3): 135-139.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4081/rt.2013.e39
Artigo de periodico
Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy (2012)
Willegaignon, José; Sapienza, Marcelo T.; Buchpiguel, Carlos A.
Source: Radiation Protection Dosimetry. Unidade: FM
Subjects: DOSIMETRIA (TÉCNICAS), NEOPLASIAS DA TIREOIDE (TERAPIA;RADIOTERAPIA), METÁSTASE NEOPLÁSICA, PROCEDIMENTOS CLÍNICOS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEGAIGNON, José e SAPIENZA, Marcelo T. e BUCHPIGUEL, Carlos A. Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy. Radiation Protection Dosimetry, v. 149, n. 2, p. 138-146, 2012Tradução . . Disponível em: https://doi.org/10.1093/rpd/ncr214. Acesso em: 05 nov. 2024.
APA
Willegaignon, J., Sapienza, M. T., & Buchpiguel, C. A. (2012). Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy. Radiation Protection Dosimetry, 149( 2), 138-146. doi:10.1093/rpd/ncr214
NLM
Willegaignon J, Sapienza MT, Buchpiguel CA. Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy [Internet]. Radiation Protection Dosimetry. 2012 ; 149( 2): 138-146.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/rpd/ncr214
Vancouver
Willegaignon J, Sapienza MT, Buchpiguel CA. Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy [Internet]. Radiation Protection Dosimetry. 2012 ; 149( 2): 138-146.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/rpd/ncr214

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em